GlassScriptPhysician profile
Kyle Mahoney
NPI 1639708332
$4,806.75
in general payments reported to CMS, 2019-2025
10 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,424 · 2022: $1,555 · 2023: $862 · 2024: $790 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,827.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $2,657.08 | 2021-2023 | |
| Stryker Corporation | $923.14 | 2022-2025 | Mako, T2 Alpha, Alphavent |
| Medtronic, INC. | $437.20 | 2021-2023 | Unid_pass |
| Integra Lifesciences Corporation | $210.25 | 2023 | Tenoglide, Integra, Integra Dermal Regeneration Template |
| Exactech, INC. | $133.30 | 2024 | |
| Osteocentric Technologies, INC. | $128.03 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2023 | Sotyktu |
| Janssen Biotech, INC. | $112.47 | 2024 | Tremfya |
| Heron Therapeutics, INC. | $46.67 | 2024 | Zynrelef |
| Linvatec Corporation | $33.61 | 2025 | Biobrace 23mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Mahoney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.